• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童苯妥英钠的负荷剂量及常规剂量治疗:血浆中母体药物及主要代谢物的动力学特征

Loading and conventional dose therapy with phenytoin in children: kinetic profile of parent drug and main metabolite in plasma.

作者信息

Wilson J T, Höjer B, Rane A

出版信息

Clin Pharmacol Ther. 1976 Jul;20(1):48-58. doi: 10.1002/cpt197620148.

DOI:10.1002/cpt197620148
PMID:132330
Abstract

Epileptic children were given phenytoin (DPH) in loading (four doses of 4.4 to 6.3 mg/kg/dose given 8-hourly and then 6 mg/kg/day) or conventional (5 to 9 mg/kg/day) doses. Plasma levels of DPH and its main metabolite (p-OH-DPH) were measured by a mass fragmentographic technique. Plasma DPH levels of more than 10 mug/ml were achieved within 16 to 38 hr in the children given loading doses and within 5 days in the conventionally dosed children. No immediate side effects were noted, but within 8 to 10 days 9 of 13 children developed a generalized skin rash. Plasma p-OH-DPH (free or conjugated) paralleled DPH during the accumulation phase but not during DPH elimination. The ratio of metabolite to DPH in plasma showed both an interindividual variation and an inverse relation to the level of DPH. Identical twins in the study had a similar ratio and plasma level-time course profile. It is concluded that the loading dose regiment achieves an appropriate plasma level of DPH rapidly, that saturation kinetics are operative for p-OH-DPH formation, that the ratio of metabolite to DPH in plasma is an individual characteristic in children, and that further studies on the delayed toxicity are needed before the loading dose regimen can be recommended.

摘要

癫痫患儿接受了苯妥英(DPH)的负荷剂量(每8小时给予4剂,每剂4.4至6.3毫克/千克,然后每天6毫克/千克)或常规剂量(每天5至9毫克/千克)治疗。采用质量碎片图谱技术测定血浆中DPH及其主要代谢产物(对羟基苯妥英,p-OH-DPH)的水平。接受负荷剂量治疗的患儿在16至38小时内血浆DPH水平达到10微克/毫升以上,接受常规剂量治疗的患儿则在5天内达到该水平。未观察到即时副作用,但在8至10天内,13名患儿中有9名出现全身性皮疹。在DPH蓄积阶段,血浆中游离或结合的p-OH-DPH与DPH平行,但在DPH消除阶段则不然。血浆中代谢产物与DPH的比值显示出个体差异,且与DPH水平呈反比关系。该研究中的同卵双胞胎具有相似的比值和血浆水平-时间过程曲线。结论是,负荷剂量方案能迅速达到适当的血浆DPH水平,对羟基苯妥英的形成存在饱和动力学,血浆中代谢产物与DPH的比值是儿童的个体特征,在推荐负荷剂量方案之前,需要对延迟毒性进行进一步研究。

相似文献

1
Loading and conventional dose therapy with phenytoin in children: kinetic profile of parent drug and main metabolite in plasma.儿童苯妥英钠的负荷剂量及常规剂量治疗:血浆中母体药物及主要代谢物的动力学特征
Clin Pharmacol Ther. 1976 Jul;20(1):48-58. doi: 10.1002/cpt197620148.
2
Plasma concentrations of 5-(4-hydroxyphenyl)-5-phenylhydantoin in phenytoin-treated patients.
Clin Pharmacol Ther. 1977 Mar;21(3):294-300. doi: 10.1002/cpt1977213294.
3
[Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].抗药物治疗的癫痫患者的血浆二苯妥英(DPH)和苯巴比妥(PB)水平(作者译)
Riv Patol Nerv Ment. 1977 Nov-Dec;98(6):363-75.
4
Carbamazepine (Tegretol) as an anticonvulsant. A controlled double-blind comparison with diphenylhydantoin (Dilantin).
Acta Neurol Scand Suppl. 1975;60:13-26. doi: 10.1111/j.1600-0404.1975.tb01383.x.
5
Is free fraction measurement of phenytoin always necessary in pediatric epileptic patients?小儿癫痫患者是否总是需要测定苯妥英的游离分数?
Ther Drug Monit. 1988;10(1):39-44.
6
[Serum diphenylhydantoin in epileptic patients (preliminary report)].
Neurol Neurochir Pol. 1977 Sep-Oct;11(5):551-4.
7
Pharmacokinetic observations of phenytoin disposition in the newborn and young infant.苯妥英在新生儿和幼儿体内处置的药代动力学观察。
Arch Dis Child. 1977 Apr;52(4):302-9. doi: 10.1136/adc.52.4.302.
8
Phenytoin metabolism in pregnancy.
Obstet Gynecol. 1980 Nov;56(5):577-82.
9
A complex pattern of disposition of phenytoin in severe intoxication.苯妥英在严重中毒时的复杂处置模式。
Clin Pharmacol Ther. 1975 Jul;18(1):112-20. doi: 10.1002/cpt1975181112.
10
Plasma levels and renal excretion of phenytoin and its metabolites in patients with renal failure.
Clin Pharmacol Ther. 1979 Sep;26(3):306-14. doi: 10.1002/cpt1979263306.

引用本文的文献

1
Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.抗癫痫药物在儿科患者中的临床药代动力学。第二部分。苯妥英、卡马西平、舒噻美、拉莫三嗪、氨己烯酸、奥卡西平和非氨酯。
Clin Pharmacokinet. 1995 Nov;29(5):341-69. doi: 10.2165/00003088-199529050-00004.
2
Pharmacokinetics and pharmacodynamics of tucaresol, an antisickling agent, in healthy volunteers.抗镰状化药物图卡索尔在健康志愿者体内的药代动力学和药效学。
Br J Clin Pharmacol. 1995 Apr;39(4):375-80. doi: 10.1111/j.1365-2125.1995.tb04465.x.
3
Rational usage of therapeutic drug monitoring in antiepileptic treatment.
抗癫痫治疗中治疗药物监测的合理应用。
Eur J Pediatr. 1980 May;133(3):193-9. doi: 10.1007/BF00496076.
4
Serum anticonvulsant concentrations and the risk of drug induced skin eruptions.血清抗惊厥药物浓度与药物性皮肤疹风险
J Neurol Neurosurg Psychiatry. 1984 Jun;47(6):642-4. doi: 10.1136/jnnp.47.6.642.
5
Formation of active metabolites of anticonvulsant drugs. A review of their pharmacokinetic and therapeutic significance.抗惊厥药物活性代谢物的形成。其药代动力学及治疗意义综述。
Clin Pharmacokinet. 1991 Jul;21(1):27-41. doi: 10.2165/00003088-199121010-00003.
6
Clinical pharmacokinetics in infants and children.婴幼儿临床药代动力学
Clin Pharmacokinet. 1976;1(1):2-24. doi: 10.2165/00003088-197601010-00002.
7
Bioavailability of three phenytoin preparations in healthy subjects and in epileptics.三种苯妥英制剂在健康受试者和癫痫患者中的生物利用度。
Eur J Clin Pharmacol. 1977 Dec 2;12(4):285-90. doi: 10.1007/BF00607428.
8
Influence of food on the absorption of phenytoin in man.食物对人体苯妥英吸收的影响。
Eur J Clin Pharmacol. 1979 May 21;15(4):269-74. doi: 10.1007/BF00618516.
9
Clinical pharmacokinetics of phenytoin.苯妥英钠的临床药代动力学
Clin Pharmacokinet. 1979 May-Jun;4(3):153-69. doi: 10.2165/00003088-197904030-00001.